Aruna Mahendravada

Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safety

Valentina Hoyos, Barbara Savoldo, Concetta Quintarelli et al. · Leukemia · 2010 · 553 citations · Full text

Anti-lymphoma/leukemia Effects, T-regulatory Cell, Hematology +8

T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model

Antonio Di Stasi, Biagio De Angelis, Cliona M. Rooney et al. · Blood · 2009 · 522 citations · Full text

Interleukin-7 Mediates Selective Expansion of Tumor-redirected Cytotoxic T Lymphocytes (CTLs) without Enhancement of Regulatory T-cell Inhibition

Serena Perna, Daria Pagliara, Aruna Mahendravada et al. · Clinical Cancer Research · 2013 · 126 citations · Full text

Regulated Expansion and Survival of Chimeric Antigen Receptor-Modified T Cells Using Small Molecule-Dependent Inducible MyD88/CD40

Aaron E. Foster, Aruna Mahendravada, Nicholas Shinners et al. · Molecular Therapy · 2017 · 103 citations · Full text

Safety and efficacy of targeting CD138 with a chimeric antigen receptor for the treatment of multiple myeloma

Chuang Sun, Aruna Mahendravada, Brandon Ballard et al. · Oncotarget · 2019 · 91 citations · Full text